Skip to content
Bispecific Antibodies: A New-Age Cancer Immunotherapy to Battle Solid Tumors

Bispecific Antibodies: A New-Age Cancer Immunotherapy to Battle Solid Tumors

Innovations in therapeutic approaches have drastically improved the outcomes of non-small cell lung cancer (NSCLC) in recent years. Among those, molecular targeted therapies, commonly involving small molecule compounds or monoclonal ...
Read More
Proteintech Distributor Training in Germany

Proteintech Distributor Training in Germany

Our colleague, Bernadett Stuhl, had the opportunity to ...
Welcoming Bio-Rad FSD Colleagues to Our Office

Welcoming Bio-Rad FSD Colleagues to Our Office

In September, we had the pleasure of hosting ...
An Outstanding Year for Proteintech Group at the 2025 CiteAb Awards!

An Outstanding Year for Proteintech Group at the 2025 CiteAb Awards!

We are delighted to share that the Proteintech ...

Let’s connect!

Inquire now for tailored lab equipment and services.

Request a quote